NIH Websites Are Changing

Get the Latest Updates and FAQs on the transition

Per Executive Order 14434 , federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Cytomegalovirus Infection: Advancing Strategies for Prevention and Treatment

September 4-6, 2018

Sponsor/Co-Sponsor(s)

Maternal and Pediatric Infectious Disease Branch (MPIDB), NICHD
National Institute of Allergy and Infectious Diseases

Location

Fishers Lane Conference Center, Room 1D13, 5601 Fishers Lane, Rockville, Maryland 20852

Purpose

Cytomegalovirus (CMV) causes significant health problems for infants who were infected in the womb and for people who become infected from organ or stem cell transplants. There is no licensed vaccine for CMV. Treatment of CMV infection is challenging because of the side effects of antiviral drugs and the emergence of drug-resistant strains. New approaches for both prevention and treatment will have a substantial public health impact.

Contact

Nahida Chakhtoura, NICHD
E-mail: nahida.chakhtoura@nih.gov

Please note: Views expressed during NICHD-sponsored events do not necessarily reflect the opinions or the official positions of NICHD, NIH, or HHS.
top of page BACK TO TOP